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MHC class I–deficient natural killer cells
acquire a licensed phenotype after transfer
into an MHC class I–sufficient environment
Julie M. Elliott,1 Joseph A. Wahle,2 and Wayne M. Yokoyama2,3
of Biology and Biomedical Sciences, 2Division of Rheumatology, Department of Medicine, and 3Howard Hughes
Medical Institute, Washington University School of Medicine, St. Louis, MO 63110

In MHC class I–deficient hosts, natural killer (NK) cells are hyporesponsive to cross-linking
of activation receptors. Functional competence requires engagement of a self–major
histocompatability complex (MHC) class I–specific inhibitory receptor, a process referred
to as “licensing.” We previously suggested that licensing is developmentally determined in
the bone marrow. In this study, we find that unlicensed mature MHC class I–deficient
splenic NK cells show gain-of-function and acquire a licensed phenotype after adoptive
transfer into wild-type (WT) hosts. Transferred NK cells produce WT levels of interferon-
after engagement of multiple activation receptors, and degranulate at levels equivalent
to WT NK cells upon coincubation with target cells. Only NK cells expressing an
inhibitory Ly49 receptor specific for a cognate host MHC class I molecule show this gainof-function. Therefore, these findings, which may be relevant to clinical bone marrow
transplantation, suggest that neither exposure to MHC class I ligands during NK development in the BM nor endogenous MHC class I expression by NK cells themselves is absolutely
required for licensing.

CORRESPONDENCE
Wayne M. Yokoyama:
yokoyama@wustl.edu
Abbreviations: 2m, 2-microglobulin; KODO, Kb–/–, Db–/–;
MFI, mean fluorescence intensity; SCT-Kb, single chain trimer
H2Kb; Tg, transgenic; TKO,
triple KO (2m–/–, Kb–/–, Db–/–).

NK cells are innate immune lymphocytes with
potent effector functions against infected and
tumor cells. NK cells integrate signals received
through target cell ligand-mediated engagement of activation receptors with those from
inhibitory receptor engagement by MHC class I
ligands expressed on targets. Absence of MHC
class I on target cells often leads to NK cell activation. This phenomenon, termed “missingself,” allows NK cells to attack and eliminate cells
with aberrantly low or absent expression of
MHC class I (Kärre et al., 1986), as with transformed or virally infected cells. Hence, NK cells
use inhibitory receptors to assess the surface of
self-tissues for MHC class I expression, providing a line of defense against pathogens and abnormal cell growth.
MHC class I molecules are also crucial to
acquisition of effector function by NK cells in
vivo as NK cells from MHC class I–deficient
hosts are defective in natural killing (Bix et al.,
1991; Höglund et al., 1991) and hyporespon
sive to triggering through their activation receptors (Fernandez et al., 2005; Kim et al., 2005).
Recent data obtained in MHC-sufficient hosts
support the hypothesis that cognate interaction
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between inhibitory receptors and self-MHC
is necessary for acquisition of effector function.
For example, Ly49C+ NK cells, which bind a
self-MHC I ligand (H2Kb) in the H2b haplotype of C57BL/6 mice, display more robust
production of cytokines upon stimulation than
NK cells expressing only Ly49A, which has
no H2b ligand (Kim et al., 2005). This is most
evident in a C57BL/6 transgenic (Tg) mouse
expressing a single-chain trimer H2Kb (SCT-Kb)
molecule, consisting of the H2Kb heavy chain
covalently linked to 2-microglobulin (2m)
and the SIINFEKL peptide from ovalbumin.
In mice where SCT-Kb is the only MHC class I
molecule expressed, i.e., SCT-Kb Tg mouse
on the Kb/Db/2m/ (triple KO; TKO)
background, and Ly49C is the sole NK cell receptor capable of binding the SCT-Kb molecule, only Ly49C+ NK cells display the licensed
phenotype (Kim et al., 2005). Thus, engagement of self–MHC-specific receptor “licenses”
© 2010 Elliott et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months
after the publication date (see http://www.rupress.org/terms). After six months it
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RESULTS AND DISCUSSION
MHC class I–deficient NK cells gain function after transfer
to MHC I-sufficient hosts
To examine potential for gain of function by hyporesponsive, peripheral MHC class I–deficient NK cells, we harvested
and labeled 2m/ splenocytes with CFSE and injected
them into MHC class I–sufficient WT (C57BL/6) or control
2m/ hosts. At day 7, host spleens were harvested and bulk
splenocytes were activated in vitro by anti-NK1.1 cross-linking,
and then analyzed for intracellular IFN-. Surprisingly, we
found that donor-derived MHC class I–deficient 2m/
NK cells in WT hosts produced IFN- at a level equivalent
to that of host WT NK cells (Fig. 1 A). In contrast, 2m/
donor cells in 2m/ hosts produced IFN- at a frequency
2074

identical to host-derived 2m/ NK cells (Fig. 1 A). This
was equivalent to the hyporesponsive production of IFN-
by NK cells from unmanipulated 2m/ control animals
(unpublished data). Therefore, adoptive transfer of hyporesponsive splenic NK cells appeared to result in the acquisition
of activation receptor responses that correlated with host NK
cell responsiveness.
It may seem surprising that donor-derived MHC-deficient
cells could be detected because WT host NK cells can eliminate MHC class I–deficient BM and splenocyte grafts (Bix et al.,
1991; Höglund et al., 1991). However, transfer of a sufficiently large number of cells can result in BM graft acceptance (Cudkowicz and Bennett, 1971; Koh et al., 2005), and
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NK cells to be functionally competent to be triggered through
their activation receptors.
Although there has been debate on the meaning of the
term “licensing,” most groups now agree that the engagement of inhibitory receptors by self–MHC class I results in
education of NK cells to become functionally competent
(Anfossi et al., 2006; Raulet and Vance, 2006). Moreover,
such education effects have also been observed with human
NK cells via self-HLA recognition by killer immunoglobulinlike receptors (KIRs), which are related by convergent evolution to murine Ly49 receptors (Kelley et al., 2005; Anfossi
et al., 2006; Yu et al., 2007; Kim et al., 2008). Thus, self–
MHC class I engagement by NK cell inhibitory receptors
appears to be a fundamental element in acquisition of NK cell
effector function.
Conventional murine NK cells are thought to develop
primarily, if not completely, in the BM where they progress
through a series of stages en route to full maturation (Di Santo,
2006; Kim et al., 2002). After this process, they leave the BM
and populate the peripheral tissues. Egress from the BM is
generally accepted as a marker of mature conventional NK
cells, as cells isolated from peripheral lymphoid tissues demonstrate effector function upon stimulation. We previously hypothesized licensing to be a developmental process because
Ly49 receptors are first expressed at an immature stage during
NK cell maturation in the BM (Kim et al., 2002). Thereafter,
developing NK cells undergo constitutive proliferation that
appears to be influenced by MHC class I and the relevant
Ly49 receptor (Kim et al., 2005). However, it is not known if
licensing can occur outside the context of development within
the BM, or whether the unlicensed phenotype is fixed.
Herein, we performed adoptive transfer of peripheral,
hyporesponsive NK cells from MHC class I–deficient donors
to MHC class I–sufficient hosts, resulting in the generation of
functional donor NK cells. Expression of a host MHC class I
ligand specific for a donor cell inhibitory NK cell receptor
was necessary for the observed gain of function, which is
highly suggestive of licensing as a mechanism. We conclude
that the unlicensed phenotype is not fixed in apparently mature peripheral NK cells, and that licensing may not be exclusively a developmental process in the BM.

Figure 1. Ly49C+ MHC class I–deficient NK cells gain function
after transfer to WT hosts. Splenocytes were purified from 2m/
donors, labeled with CSFE, and adoptively transferred i.v. into WT
(C57BL/6) or 2m/ hosts. Recipient splenocytes were harvested at day 7,
stimulated with anti-NK1.1, and analyzed for intracellular IFN-.
(A) Representative dot plots depict IFN- production versus Ly49C expression on gated donor (CSFE+) or host (CSFE) NKp46+ CD3 NK cells. Numbers indicate percentage of cells in each quadrant. (B) Summary of IFN-
production by Ly49C+ (left) and Ly49C (right) donor (2m/) and host
NK cells recovered 7 d after adoptive transfer into WT or 2m/ hosts
after anti-NK1.1 stimulation. Results from anti-NK1.1 stimulation of unmanipulated WT NK cells are shown. Data are pooled from three independent experiments, with three to five mice/group. Means are shown as
horizontal lines with error bars representing SEM.
Plasticity in NK cell licensing | Elliott et al.
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Gain of function is restricted to cells expressing inhibitory
Ly49 receptor specific for host MHC class I
We next examined if the NK cells acquiring function had
properties of licensed NK cells. Such cells would be expected
to express a receptor specific for an MHC class I allele in the
WT host. In particular, Ly49C is an inhibitory NK cell receptor with an H2b ligand, H2Kb (Kim et al., 2005). We hypothesized that if transfer of hyporesponsive 2m/ NK cells into
an H2b environment results in licensing, we would observe a
higher frequency of IFN-+ donor NK cells among the
Ly49C+ population than the Ly49C population. Indeed,
transferred 2m/ Ly49C+ NK cells made IFN- at a significantly higher frequency than Ly49C NK cells (P = 0.02;
Fig. 1 B). Additionally, similar results were observed after stimulation through another NK cell activation receptor, Ly49H
(Fig. S4). Therefore, after adoptive transfer of MHC-deficient
JEM VOL. 207, September 27, 2010

splenocytes into MHC class I–expressing hosts, there is a selective gain of function in NK cells expressing an inhibitory
receptor capable of interacting with host MHC class I.
To extend these findings to other inhibitory Ly49 receptors and MHC ligands, we transferred 2m/ NK cells into
KODO (Kb/Db/) D8 hosts, which lack H2b MHC class Ia
heavy chains and display Tg expression of H2Dd, a ligand
for Ly49A (Karlhofer et al., 1992). After transfer, we observed a gain in IFN- production among Ly49A+ MHC
class I–deficient NK cells (Fig. 2 A), consistent with enhanced
responsiveness of Ly49A+ NK cells in H2Dd-expressing mice
(Kim et al., 2005). Thus, we confirmed that there was a selective gain of function for transferred NK cells expressing
another inhibitory receptor able to bind to a different host
MHC class I molecule.
We consistently observed that Ly49C– NK cells in WT
hosts, and Ly49A– NK cells in KODO D8 hosts, trended toward greater IFN- production than their counterparts from
MHC class I–deficient hosts (Fig. 1 and Fig. 2 A). Although
these findings were not statistically significant, we hypothesized that expression of other self-MHC–specific receptors
may contribute to this effect. To investigate this hypothesis,
we transferred 2m/ NK cells into SCT-Kb Tg TKO hosts,
which express only a single MHC class I molecule (SCT-Kb)

Figure 2. Inhibitory receptor and cognate MHC I ligand are required for gain-of-function. (A) Summary of IFN- production by
Ly49A+ (left) and Ly49A (right) donor (2m/) and host NK cells recovered 7 d after adoptive transfer from 2m/ or KODO D8 (KD8) hosts
after anti-NK1.1 stimulation. Results from anti-NK1.1 stimulation of unmanipulated KODO D8 NK cells are shown. Data were pooled from four
independent experiments, with three to eight mice/group. (B) Summary of
IFN- production by Ly49C+ (left) or Ly49C (right) donor (2m/) or
host NK cells recovered 7 d after adoptive transfer from 2m/ or
SCT-Kb Tg TKO (SCT) hosts, after ex vivo stimulation via anti-NK1.1.
Results from anti-NK1.1 stimulation of unmanipulated SCT NK cells are
shown. Data were pooled from three independent experiments with three
to seven mice/group. Means are shown as horizontal lines with error bars
representing SEM.
2075
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we suspect the same process may be occurring here. Regardless, host NK cells did not demonstrate increased responsiveness as compared with NK cells from unmanipulated controls
(Fig. 1 B) and did not display markers associated with activation (not depicted). Thus, we found no evidence for host NK
cell activation that may have accounted for the phenotypic
change in the donor NK cells.
It was possible that the gain of function observed for
transferred MHC class I–deficient cells could be caused by
their coincubation with WT splenocytes during in vitro
stimulation. To test this possibility, we mixed freshly isolated
2m/ and WT splenocytes at various ratios and stimulated
them under the conditions used for the analyses of adoptively
transferred cells. Regardless of the presence of WT cells in
co-culture, 2m/ NK cells retained their hyporesponsive
phenotype after receptor cross-linking (Fig. S1). These results
indicate that the gain of function of the 2m/ NK cells
after adoptive transfer to WT hosts is imparted during residence in the MHC class I–sufficient environment, not during
co-culture and stimulation.
As we and others have recently shown that previously activated NK cells exhibit a memory-like property of enhanced
cytokine production upon restimulation (Cooper et al., 2009;
Sun et al., 2009), we sought to determine if our current results could reflect prior donor NK cell activation. Although
kinetic studies revealed that donor NK cells gained function
at WT levels by day 4 after transfer and that their phenotype
was stable thereafter (Fig. S2), donor 2m/ NK cells did
not spontaneously produce IFN- or display markers of activation, such as CD69, at any time (Fig. S3 and not depicted).
Prior studies also showed that previously activated NK cells
displaying the memory-like phenotype preferentially proliferate upon transfer (Cooper et al., 2009; Sun et al., 2009).
In contrast, donor 2m/ NK cells did not proliferate after
residence in WT hosts, as indicated by a lack of CFSE dilution
(Fig. S3 A). Collectively, these data indicate that 2m/ NK
cells were not activated after adoptive transfer to WT hosts,
suggesting that acquisition of functional competence is un
related to a memory-like phenotype.

Published September 6, 2010

that binds only one NK cell receptor, Ly49C (Kim et al., 2005).
After adoptive transfer, donor Ly49C+ NK cells gained the
ability to produce IFN- at levels equivalent to that of host
Ly49C+ cells (Fig. 2 B). However, there was no increase in
IFN- production by either donor or host Ly49C NK cells.
Therefore, the interaction between an inhibitory Ly49 receptor and its cognate self–MHC class I ligand is necessary
for the gain of function observed in hyporesponsive MHC
class I–deficient NK cells after their adoptive transfer to
MHC class I–sufficient hosts, consistent with licensing.

Specific decrease in inhibitory receptor MFI on MHC
class I–deficient cells after transfer
Previous studies indicate that splenic NK cells from 2mdeficient animals are mature and indistinguishable from peri
pheral NK cells in WT mice (Huntington et al., 2007; Joncker
and Raulet, 2008; Kim et al., 2002; Sun and Lanier, 2008).
Nevertheless, one potential mechanism for the gain of function by transferred 2m/ NK cells could be differentiation
of the NK cells after transfer. To further evaluate this possibility, the surface phenotype of 2m/ donor cells was assessed after recovery from WT hosts at 7 d after adoptive
transfer, a time when donor cells possess the capacity for normal cytokine production and degranulation (Fig. S2 and
Fig. 3). These experiments indicate that, regardless of the
genotype of the host or donor, all NK cells appeared phenotypically indistinguishable in most aspects. For example, markers such as NK1.1, CD94, NKG2A, CD69, DX5, and 2B4
showed no difference in expression between 2m/ and
WT NK cells, before or after adoptive transfer (Fig. 4). Other
markers, such as NKp46, NKG2D, and CD11b were expressed
2076
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Gain of function extends to NK cell degranulation
MHC class I–deficient NK cells are defective in their cytokine production capacity and in their ability to kill targets as
compared with WT NK cells (Bix et al., 1991; Höglund et al.,
1991). As killing is dependent on degranulation, we exposed
transferred NK cells to sensitive targets and assessed the level
of surface CD107a (LAMP-1), a marker for NK cell degranulation (Fig. 3). Additionally, NK cells were assessed after
transfer into Jinx mice, which have a mutation in Unc13d
(Crozat et al., 2007). The Jinx mice provide the baseline level
of CD107a staining because their NK cells are unable to degranulate. After transfer to MHC class I–expressing hosts,
2m/ NK cells gained the ability to degranulate at a level
equivalent to that of host and control WT NK cells in response to YAC targets (Fig. 3). In contrast, 2m/ NK cells
adoptively transferred to 2m/ hosts show defective degranulation, comparable to Jinx NK cells. Furthermore, as
with cytokine production, we found no increase in the ability of freshly isolated 2m/ NK cells to degranulate in response to target cells when coincubated with WT NK cells in
the degranulation assay (Fig. S5). Collectively, these data indicate that the gain of function (degranulation) observed in
MHC class I–deficient cells is acquired after their residence
in the WT host environment.

at a slightly higher level on WT NK cells when compared
with 2m/ NK cells, and their expression slightly increased
on 2m/ NK cells after their transfer to WT hosts. Therefore, there were minimal changes overall in the expression of
most surface molecules after adoptive transfer of 2m/ cells
to WT hosts.
In contrast to the minimal changes in expression of most
surface markers, we found a distinct and reproducible decrease of Ly49C mean fluorescence intensity (MFI) on MHC
class I–deficient cells after adoptive transfer to WT C57BL/6
hosts (Fig. 5 A). This effect was observed for multiple systems
in which the inhibitory Ly49 receptors had a known MHC
class I ligand in the host (Fig. 5, A–C). In particular, decreased

Figure 3. MHC class I–deficient NK cells gain WT degranulation
capacity after adoptive transfer into MHC class I–sufficient hosts.
Splenocytes were purified from 2m/ donors and adoptively transferred
into WT, 2m/ or Jinx hosts. On day 7, recipient splenocytes were harvested, coincubated with YAC target cells, and assayed for surface CD107a
expression. (A) Representative dot plots showing CD107a expression on
NK cells gated on Ly5.1+ (donor) or Ly5.1 (host) CD3NK1.1+ cells. Figures
show the percentage of cells positive for CD107a staining. (B) Summary of
CD107a surface expression by host and donor NK cells after incubation
with target cells. Data are representative from three independent experiments, with two to three mice/group for adoptive transfer donor and host
cells, and one to two mice/group for controls. Means are shown as horizontal lines with error bars representing SEM.
Plasticity in NK cell licensing | Elliott et al.
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Figure 4. Minimal changes in surface phenotype of MHC class I–
deficient NK cells after adoptive transfer to WT hosts. At day 7 after
adoptive transfer of 2m/ splenocytes to WT hosts, unstimulated NK
cells were assessed for NK receptor or marker expression by flow cytometry. Control staining of NK cells from unmanipulated WT or 2m/ mice
are shown. Data are representative from two experiments per condition,
with each point representing one individual spleen. Mean MFI is shown as
horizontal bars. *, P < 0.02; **, P < 0.002; ***, P < 0.0005.
JEM VOL. 207, September 27, 2010

have become fully mature. Thus, although it is possible that
licensing may occur during NK cell development in vivo,
these results demonstrate that licensing is not exclusively a
developmental process in the BM.
In the current experiments, adoptive transfer of NK cells
from an MHC-deficient background was performed without
host irradiation and subset depletion, thereby minimizing the
impact of experimental manipulation on host and donor NK
cells. Because WT host NK cells can reject MHC class I–
deficient grafts (Bix et al., 1991; Höglund et al., 1991), it is
possible that host NK cells could have been activated and
influenced the function of transferred donor cells. However,
we found no evidence of any host NK cell activation. Most
importantly, restriction of the gain of function to only those
NK cells bearing an inhibitory receptor specific for selfMHC, as was observed, would not be expected if NK cells
had been activated by a broad stimulus, such as cytokine
stimulation. Thus, it appears that acquisition of activation receptor responsiveness by the MHC-deficient NK cells is a
cell-intrinsic property, consistent with a licensed phenotype.
NK cell receptor–ligand interactions can occur in either
trans (on different cells) or in cis (on the same NK cell). Importantly, the licensed phenotype of the donor MHCdeficient NK cells in the MHC-sufficient environment indicates
that NK cell-intrinsic expression of MHC class I is not strictly
a requirement for licensing. This seems to be consistent with
trans effects and contradictory to studies suggesting that cis
interactions are necessary for education (Chalifour et al., 2009).
However, numerous works indicate that NK cells can acquire

Figure 5. Specific reduction in inhibitory Ly49 receptor expression
on MHC I-deficient donor NK cells after adoptive transfer into
MHC class I–expressing hosts. Splenocytes from 2m/ donors were
adoptively transferred into indicated hosts. At day 7, unstimulated recipient splenocytes were assessed for Ly49C (A and B) or Ly49A (C and D)
surface expression. Control staining from unmanipulated mice are shown,
as indicated. Data are from two to three experiments per condition, with
each point representing one individual spleen. Mean MFI is shown as
horizontal bars. **, P < 0.004; ***, P < 0.0001.
2077
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Ly49C MFI was specifically observed in cells transferred to the
SCT-Kb Tg TKO mice (Fig. 5 B), whereas MFI of Ly49A, a
receptor for which no MHC class I ligand is present in this host,
remained unchanged (Fig. 5 D). However, Ly49A MFI decreased on cells transferred into KODO D8 mice that express
the ligand for Ly49A (Fig. 5 C). Thus, decreased Ly49 MFI appears to reflect a specific interaction of an inhibitory receptor on
a donor NK cell with a host MHC class I molecule.
Herein, we found that introduction of MHC class I–
deficient NK cells into an MHC class I–sufficient host results
in their acquisition of function, as demonstrated by their increased capacity for cytokine production and degranulation
upon activation receptor cross-linking. The requirement that
MHC class I–deficient NK cells express an inhibitory receptor specific for host MHC class I to become functional can be
interpreted as evidence that these cells become licensed in the
MHC class I–sufficient host. Importantly, these experiments
suggest that licensing of NK cells can occur after their egress
from the BM, after the time at which they are believed to

Published September 6, 2010

MATERIALS AND METHODS
Mice. C57BL/6 mice were purchased from the National Cancer Institute
(Frederick, MD). C57BL/6 Ly5.1 congenic mice and 2m/ mice were
purchased from The Jackson Laboratory. 2m/ Ly5.1 mice were generated by crossing 2m/ mice with Ly5.1 mice (both from The Jackson
Laboratory). H2Kb/H2Db/H2Dd-expressing mice (KODO D8) were
generated by crossing H2Kb/H2Db/ mice (Taconic Farms) with mice
expressing a Dd-transgene (D8), provided by D. Marguiles (National Institute of Allergy and Infectious Diseases, Bethesda, MD). TKO Kb/
Db/2m/ mice with Tg expression of Kb-OVA MHC class I as a
single protein (SCT-Kb Tg TKO mice) were a gift from T. Hansen
(Washington University, Saint Louis, MO). Jinx mice, harboring a mutation in UNC13D, were provided by B. Beutler (Scripps Research Institute, La Jolla, CA) and have been previously described (Crozat et al.,
2007). Genotyping was performed by the Speed Congenics core facility,
supported by the Rheumatic Disease Core Center grant to Washington
University. Animals were housed in specific pathogen–free facilities at
Washington University in Saint Louis, and all mice were used between
6 and 14 wk of age. Experiments were conducted in accordance with the
animal protocol approved by the Animal Studies Committee at Washington University in Saint Louis.
2078

Antibodies and flow cytometry. The following antibodies and reagents
were purchased from BD: anti-CD3 (145-2C11), anti-Ly5.1 (A20), antiLy5.2 (104), anti-NK1.1 (PK136), anti-Ly49A (JR9 and A1), anti-CD69
(H1.2F3), streptavidin APC (SA-APC), SA-PerCP-Cy5.5, and SA-PE-Cy7.
The following antibodies were purchased from eBioscience: anti-NKp46
(29A1.4), anti-IFN- (XMG1.2), anti-KbOVA (eBio25-D1.16), anti-CD94
(18d3), anti-NKG2D (CX5), anti-CD11b (M1/70), anti-CD127 (A7R34),
anti-CD49 (DX5), and anti-CD107a (eBio1D4B). Anti-Ly49C (4LO33)
and anti-Ly49H were purified in our laboratory from hybridoma supernatants. (The 4LO33 hybridoma was generously provided by Suzanne Lemieux,
Institut National de la Recherche Scientifique-Institut Armand-Frappier,
Laval, Quebec, Canada.) All surface staining was performed on ice in staining buffer (3% FCS, 0.1% NaN3 in PBS) containing anti-FcR antibodies
(2.4G2). Samples were collected on a FACSCanto (BD) using FACSDiva
software (BD), and data were analyzed using FlowJo (Tree Star, Inc.).
Adoptive transfer and co-culture. For adoptive transfer experiments, donor
splenocytes were purified from 2m/ mice, red-blood cell lysed, and la
beled with 1 µM CFSE (CellTrace; Invitrogen). Cells were washed twice in
PBS and resuspended at 2.5 × 108 splenocytes/ml PBS. 200 µl of the cell suspension was injected into the lateral tail vein of age- and sex-matched recipient
mice. For co-culture experiments, freshly isolated RBC-lysed splenocytes
from C57BL/6 Ly5.1 and 2m/ donors were plated in 6-well plates at ratios
indicated in the figures, with 1.0 × 107 cells/ml of R10 media (RPMI, 10%
FCS, l-glutamine, and pen-strep)/well. For the kinetic analysis, a single donor
population was prepared and injected into multiple recipients, which were
analyzed on varying days after transfer using the same set of reagents.
In vitro stimulation and intracellular cytokine staining. Splenocytes
were harvested from adoptive transfer recipients 7 d after transfer and stimulated with anti-NK1.1 (or anti-Ly49H) mAb as previously described (Kim
et al., 2005). In brief, 107 splenocytes were plated into 6-well plates, that
were either precoated with antibody (5 µg/ml; 1.5 h at 37°C), contained
media alone, or contained media with 0.5 µg phorbol myristate acetate
(Sigma-Aldrich) and 4 µg ionomycin (Calbiochem). Cells were incubated
for 1 h at 37°C in 5%CO2. Brefeldin A (GolgiPlug; BD) was added, and cells
were incubated for an additional 7 h. Cells were then fixed and permeabilized (Cytofix/Cytoperm; BD), followed by antibody staining for intracellular IFN-, as previously described (Kim et al., 2005).
Degranulation assay. Splenocytes were harvested from adoptive-transfer
recipients at day 7 after transfer, and NK cells were purified using magnetic
separation columns (MACS NK isolation kit; Miltenyi Biotech,). Separation
purity was determined via flow cytometry (gating on CD3 NK1.1+ cells),
and NK cells were plated with target cells at a ratio of 1:1 (E:T) in 96-well
V-bottom plates. Anti-CD107a antibody and monensin (eBioscience) were
added to each well before incubation. Plates were incubated for 2 h at 37°C,
after which surface staining for flow cytometry was performed as described
in Antibodies and flow cytometry.
Statistical analysis. Data are presented as mean ± SD. Statistics were generated using unpaired Student’s t test within GraphPad Prism software
(GraphPad), and P values <0.05 were considered significant.
Online supplemental material. Fig. S1 shows MHC class I–deficient and
WT NK cells retain distinct cytokine production phenotypes during splenocyte co-culture. Fig. S2 shows MHC class I–deficient NK cells gain function
72 h after transfer into WT hosts. Fig. S3 shows that MHC class I–deficient
NK cells do not proliferate and do not constitutively produce IFN- after
adoptive transfer into WT hosts. Fig. S4 shows selective gain-of-function by
MHC class I–deficient NK cells expressing an inhibitory receptor specific for
host-MHC class I after activation through an alternate stimulus. Fig. S5 shows
that MHC class I–deficient and WT NK cells retain distinct degranulation
phenotypes during splenocyte co-culture. Online supplemental material is
available at http://www.jem.org/cgi/content/full/jem.20100986/DC1.
Plasticity in NK cell licensing | Elliott et al.
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plasma membrane components from other cells, in a process
termed trogocytosis (Carlin et al., 2001; Sjöström et al., 2001;
Zimmer et al., 2001). This may result in the accumulation
of enough cognate MHC ligand on the surface of 2m/
donor NK cells sufficient to induce the licensing state by cis
interactions. Previous studies have suggested that the decreased
MFI in this context can be caused, at least in part, by cis
interactions (Zimmer et al., 2001; Andersson et al., 2007).
Consistent with this possibility, we found a correlation between decreased MFI for a Ly49 receptor specific for host
MHC and the licensed phenotype. Importantly, a similar decrease in inhibitory receptor MFI was reported after adoptive
transfer of WT splenocytes to hosts with Tg MHC I-expression
(Kåse et al., 1998), supporting our observations and suggest
ing that the phenomenon of decreased inhibitory receptor
MFI after exposure to MHC I is not an irregularity of MHC Ideficient cells. Regardless of the mechanism, our data indicate that NK cells may not need to produce their own MHC
ligand to be licensed.
In summary, our data indicate that NK cell function in
respect to host MHC environment is more plastic than originally anticipated, as in vivo exposure of a peripheral cell to
the presence of an inhibitory ligand can alter the functional
capacity of the NK cell. As such, these results may have important clinical implications. In particular, patients undergoing BM transplantation experience greater donor-mediated
anti-leukemic effect when donor NK cells express KIRs specific for HLA lacking in the patient (for review see Grzywacz
et al., 2008). Therefore, within the context of the transfer of
peripheral NK cells, such as NK immunotherapy, donor NK
cells unlicensed by HLA alleles absent in the donor may become licensed by host HLA alleles, leading to a beneficial
gain in reactivity of donor NK cells against host tumors lacking HLA expression. Perhaps prospective pairing of donor
KIR along with donor and host HLA to anticipate gain of
function by otherwise unlicensed donor NK cells may enhance patient outcomes.
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